mianserin has been researched along with Rhabdomyolysis in 6 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Serotonin syndrome is a potentially life-threatening complication of serotonergic agents." | 6.52 | Serotonin Syndrome Induced by Combined Use of Mirtazapine and Olanzapine Complicated with Rhabdomyolysis, Acute Renal Failure, and Acute Pulmonary Edema-A Case Report. ( Ong, CT; Sung, SF; Tong, SH; Wu, CS, 2015) |
| "Mirtazapine was introduced and quetiapine increased." | 5.48 | Severe rhabdomyolysis induced by quetiapine and mirtazapine in a French military soldier. ( Delacour, H; Keou, S; Lahutte, B; Mennessier, C; Ratnam, C; Saguin, E, 2018) |
| " A re-evaluation of its pharmacological treatment with the introduction of mirtazapine (30 mg/day) was associated with a rhabdomyolysis (CK> 20,000 IU/L at day 3)." | 3.88 | [Antipsychotic induced rhabdomyolysis]. ( Delacour, H; Keou, S; Lahutte, B; Mennessier, C; Plantamura, J; Ratnam, C; Saguin, E, 2018) |
| "Serotonin syndrome is a potentially life-threatening complication of serotonergic agents." | 2.52 | Serotonin Syndrome Induced by Combined Use of Mirtazapine and Olanzapine Complicated with Rhabdomyolysis, Acute Renal Failure, and Acute Pulmonary Edema-A Case Report. ( Ong, CT; Sung, SF; Tong, SH; Wu, CS, 2015) |
| "Mirtazapine was introduced and quetiapine increased." | 1.48 | Severe rhabdomyolysis induced by quetiapine and mirtazapine in a French military soldier. ( Delacour, H; Keou, S; Lahutte, B; Mennessier, C; Ratnam, C; Saguin, E, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saguin, E | 2 |
| Keou, S | 2 |
| Ratnam, C | 2 |
| Mennessier, C | 2 |
| Delacour, H | 2 |
| Lahutte, B | 2 |
| Plantamura, J | 1 |
| Wu, CS | 1 |
| Tong, SH | 1 |
| Ong, CT | 1 |
| Sung, SF | 1 |
| Kuliwaba, A | 1 |
| Zink, M | 1 |
| Knopf, U | 1 |
| Argiriou, S | 1 |
| Kuwilsky, A | 1 |
1 review available for mianserin and Rhabdomyolysis
| Article | Year |
|---|---|
Serotonin Syndrome Induced by Combined Use of Mirtazapine and Olanzapine Complicated with Rhabdomyolysis, Acute Renal Failure, and Acute Pulmonary Edema-A Case Report.
Topics: Acute Disease; Acute Kidney Injury; Adult; Benzodiazepines; Humans; Male; Mianserin; Mirtazapine; Ol | 2015 |
5 other studies available for mianserin and Rhabdomyolysis
| Article | Year |
|---|---|
Severe rhabdomyolysis induced by quetiapine and mirtazapine in a French military soldier.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; France; Humans; Male; Mianserin; Mili | 2018 |
[Antipsychotic induced rhabdomyolysis].
Topics: Adult; Antipsychotic Agents; Humans; Male; Mianserin; Mirtazapine; Rhabdomyolysis; Stress Disorders, | 2018 |
Mirtazapine: rhabdomyolysis.
Topics: Antidepressive Agents, Tricyclic; Humans; Mianserin; Mirtazapine; Pharmacovigilance; Rhabdomyolysis | 2014 |
Non-lethal mirtazapine overdose with rhabdomyolysis.
Topics: Adult; Antidepressive Agents, Tricyclic; Depression; Drug Overdose; Humans; Male; Mianserin; Mirtaza | 2005 |
A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Comorbidity; Depressive Disorder, Maj | 2006 |